» Articles » PMID: 30159030

Astaxanthin Overproduction in Yeast by Strain Engineering and New Gene Target Uncovering

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2018 Aug 31
PMID 30159030
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Astaxanthin is a natural carotenoid pigment with tremendous antioxidant activity and great commercial value. Microbial production of astaxanthin via metabolic engineering has become a promising alternative. Although great efforts have been conducted by tuning the heterologous modules and precursor pools, the astaxanthin yields in these non-carotenogenic microorganisms were still unsatisfactory for commercialization, indicating that in addition to targeted tailoring limited targets guided by rationally metabolic design, combining more globe disturbances in astaxanthin biosynthesis system and uncovering new molecular mechanisms seem to be much more crucial for further development. Since combined metabolic engineering with mutagenesis by screening is a powerful tool to achieve more global variations and even uncover more molecular targets, this study would apply a comprehensive approach integrating heterologous module engineering and mutagenesis by atmospheric and room temperature plasma (ARTP) to promote astaxanthin production in .

Results: Here, compared to the strain with β-carotene hydroxylase (CrtZ) from sp. strain PC-1, involving new CrtZ from enhanced astaxanthin yield to 1.78-fold and increased astaxanthin ratio to 88.7% (from 66.6%). Astaxanthin yield was further increased by 0.83-fold (to 10.1 mg/g DCW) via ARTP mutagenesis, which is the highest reported yield at shake-flask level in yeast so far. Three underlying molecular targets (, - and ) associated with astaxanthin biosynthesis were first uncovered by comparative genomics analysis. To be noted, individual deletion of can recover 75.6% improvement on astaxanthin yield achieved by ARTP mutagenesis, indicating was a very promising molecular target for further development. Eventually, 217.9 mg/L astaxanthin (astaxanthin ratio was 89.4% and astaxanthin yield was up to 13.8 mg/g DCW) was obtained in 5-L fermenter without any addition of inducers.

Conclusions: Through integrating rational engineering of pathway modules and random mutagenesis of hosts efficiently, our report stepwise promoted astaxanthin yield to achieve the highest reported one in yeast so far. This work not only breaks the upper ceiling of astaxanthin production in yeast, but also fulfills the underlying molecular targets pools with regard to isoprenoid microbial overproductions.

Citing Articles

Engineering of the fast-growing cyanobacterium Synechococcus sp. PCC 11901 to synthesize astaxanthin.

Betterle N, Gasparotto E, Battagini E, Ceschi E, Bellamoli F, Nixon P Biotechnol Biofuels Bioprod. 2025; 18(1):28.

PMID: 40022248 PMC: 11871721. DOI: 10.1186/s13068-025-02626-5.


Engineering Saccharomyces cerevisiae for medical applications.

Maneira C, Chamas A, Lackner G Microb Cell Fact. 2025; 24(1):12.

PMID: 39789534 PMC: 11720383. DOI: 10.1186/s12934-024-02625-5.


Metabolic Engineering of for Production of Canthaxanthin, Zeaxanthin, and Astaxanthin.

Promdonkoy P, Watcharawipas A, Bubphasawan S, Sansatchanon K, Suwanakitti N, Kocharin K J Fungi (Basel). 2024; 10(6).

PMID: 38921419 PMC: 11205050. DOI: 10.3390/jof10060433.


Identification of a novel metabolic engineering target for carotenoid production in Saccharomyces cerevisiae via ethanol-induced adaptive laboratory evolution.

Su B, Li A, Deng M, Zhu H Bioresour Bioprocess. 2024; 8(1):47.

PMID: 38650275 PMC: 10992865. DOI: 10.1186/s40643-021-00402-5.


Biotechnological advances for improving natural pigment production: a state-of-the-art review.

Lyu X, Lyu Y, Yu H, Chen W, Ye L, Yang R Bioresour Bioprocess. 2024; 9(1):8.

PMID: 38647847 PMC: 10992905. DOI: 10.1186/s40643-022-00497-4.


References
1.
Guo D, Ji X, Ren L, Li G, Yin F, Huang H . Development of a real-time bioprocess monitoring method for docosahexaenoic acid production by Schizochytrium sp. Bioresour Technol. 2016; 216:422-7. DOI: 10.1016/j.biortech.2016.05.044. View

2.
Fraser P, Miura Y, Misawa N . In vitro characterization of astaxanthin biosynthetic enzymes. J Biol Chem. 1997; 272(10):6128-35. DOI: 10.1074/jbc.272.10.6128. View

3.
Yang K, Duley M, Zhu J . Metabolomics Study Reveals Enhanced Inhibition and Metabolic Dysregulation in Escherichia coli Induced by Lactobacillus acidophilus-Fermented Black Tea Extract. J Agric Food Chem. 2018; 66(6):1386-1393. DOI: 10.1021/acs.jafc.7b04752. View

4.
Misawa N . Carotenoid β-ring hydroxylase and ketolase from marine bacteria-promiscuous enzymes for synthesizing functional xanthophylls. Mar Drugs. 2011; 9(5):757-771. PMC: 3111180. DOI: 10.3390/md9050757. View

5.
Lin Y, Chang J, Lin H, Thia C, Kao Y, Huang C . Metabolic engineering a yeast to produce astaxanthin. Bioresour Technol. 2017; 245(Pt A):899-905. DOI: 10.1016/j.biortech.2017.07.116. View